Back
Ginkgo Bioworks Holdings Vs. Perspective Therapeutics Industry Stock Comparison
Sell
45
DNA
Ginkgo Bioworks Holdings
Last Price:
9.44
Seasonality Move:
-37.29%
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.49
Seasonality Move:
27.93%
Sell
45
Ginkgo Bioworks Holdings (DNA)
is a Sell
Is Ginkgo Bioworks Holdings a Buy, Sell or Hold?
- The current Ginkgo Bioworks Holdings [DNA] share price is $9.44. The Score for DNA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- DNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.48. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DNA Stock Price Chart
What is Ginkgo Bioworks Holdings's stock price today?
-
The Ginkgo Bioworks Holdings share price today is $9.44
The current trend is moderately bullish and DNA is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.
DNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 52.26 | Buy |
| Chaikin Money Flow: | -1056113 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.11 - 10.27) | Buy |
| Bollinger Bands (100): | (6.57 - 10.81) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 22.44 | Sell |
| Chaikin Money Flow: | 421257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.89 - 8.29) | Sell |
| Bollinger Bands (100): | (7.6 - 15.16) | Sell |
DNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.49 | Sell |
| 20-day SMA: | 8.78 | Buy |
| 50-day SMA: | 8.41 | Buy |
| 200-day SMA: | 19.42 | Sell |
| 8-day EMA: | 10.1 | Sell |
| 20-day EMA: | 9.38 | Buy |
| 50-day EMA: | 8.89 | Buy |
| 200-day EMA: | 20.54 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.63 | Sell |
| 20-day SMA: | 4.4 | Sell |
| 50-day SMA: | 9 | Sell |
| 200-day SMA: | 12.37 | Sell |
| 8-day EMA: | 3.7 | Sell |
| 20-day EMA: | 4.97 | Sell |
| 50-day EMA: | 7.85 | Sell |
| 200-day EMA: | 10.37 | Sell |
Ginkgo Bioworks Holdings Earnings Growth & DNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.47 per share, and an increase next year of $0.03 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Ginkgo Bioworks Holdings Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||